Rapid drug desensitization in children: A single‐center experience
Pediatric Allergy and Immunology · 2026-03 · 37 (3)
DOI: 10.1111/pai.70312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 09.03.2026. Verfasst von Çağrı Torun Özel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Immunology, Ankara Bilkent City Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Drug Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Drug hypersensitivity reactions (HSRs) in children often necessitate discontinuation of essential therapies. Rapid drug desensitization (RDD) is a key strategy to enable safe re‐exposure; however, pediatric data remain limited.
Methods
This retrospective study included 59 pediatric patients (0–18 years) who underwent RDD between September 2019 and January 2025 at a tertiary pediatric allergy center. Demographics, HSR characteristics, premedication strategies, desensitization protocols, and breakthrough reactions (BRs) were analyzed. A total of 1978 procedures were performed using 62 protocols for 27 different drugs, including antimicrobials, enzyme replacement therapies (ERTs), immunomodulators, chemotherapeutics, and other agents.
Results
Fifty‐nine patients underwent 1978 RDD procedures. Of these, 58 patients successfully completed desensitization, while treatment modification was required in one patient. In total, 1977 protocols were successfully completed, with only one protocol failure, corresponding to an overall success rate exceeding 99%. BRs reactions occurred in 0.6% ( n = 12) of procedures; most were mild to moderate and effectively managed without discontinuation of the protocol. Premedication regimens were individualized according to the drug administered and patient characteristics.
Conclusion
This study represents one of the largest pediatric RDD series to date, demonstrating high efficacy and a favorable safety profile across a wide range of drug classes. Pediatric RDD should be considered a reliable therapeutic option in children with drug hypersensitivity when alternatives are lacking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Allergy and Immunology, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Department of Pediatric Allergy and Immunology, Dr. Burhan Nalbantoğlu State Hospital, Nicosia, Cyprus.
ORCID-Profile: Çağrı Torun Özel, Aslı Kuzu Kuşaklı, Azize Pınar Metbulut, Ahmet Selmanoğlu, Zeynep Şengül Emeksiz, Emine Dibek Mısırlıoğlu
Zitieren
APA
Torun Özel, Ç., Kuzu Kuşaklı, A., Metbulut, A. P., Selmanoğlu, A., Şengül Emeksiz, Z., & Dibek Mısırlıoğlu, E. (2026). Rapid drug desensitization in children: A single‐center experience. Pediatric Allergy and Immunology, 37(3). https://doi.org/10.1111/pai.70312
Vancouver
Torun Özel Ç, Kuzu Kuşaklı A, Metbulut AP, Selmanoğlu A, Şengül Emeksiz Z, Dibek Mısırlıoğlu E. Rapid drug desensitization in children: A single‐center experience. Pediatric Allergy and Immunology. 2026;37(3). doi:10.1111/pai.70312
BibTeX
@article{Torunzel2026,
author = {Torun Özel, Çağrı and Kuzu Kuşaklı, Aslı and Metbulut, Azize Pınar and Selmanoğlu, Ahmet and Şengül Emeksiz, Zeynep and Dibek Mısırlıoğlu, Emine},
title = {Rapid drug desensitization in children: A single‐center experience},
journal = {Pediatric Allergy and Immunology},
year = {2026},
volume = {37},
number = {3},
doi = {10.1111/pai.70312}
}
EUVIMED